null

SMILES: CCOP(=O)(OCC)c1nc2ccccc2n([C@@H]2C[C@@H]3CC[C@H](C2)N3C23CC4CC2CC(C3)C4)c1=O

InChI Key: InChIKey=CVBWYFBEARUZOC-LJCUTECVSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 303061   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM303061 (US9598447, Ref No. AA) Show SMILES CCOP(=O)(OCC)c1nc2ccccc2n([C@@H]2C[C@@H]3CC[C@H](C2)N3C23CC4CC2CC(C3)C4)c1=O |r,TLB:28:27:32:29.30,THB:25:24:17.18.23:20.21,28:29:32:33.27.26,30:31:29.28:26| Show InChI InChI=1S/C28H38N3O4P/c1-3-34-36(33,35-4-2)26-27(32)30(25-8-6-5-7-24(25)29-26)23-14-21-9-10-22(15-23)31(21)28-16-18-11-19(17-28)13-20(28)12-18/h5-8,18-23H,3-4,9-17H2,1-2H3/t18?,19?,20?,21-,22+,23+,28?	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	31.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purdue Pharma L.P. US Patent					Assay Description κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...				US Patent US9598447 (2017) BindingDB Entry DOI: 10.7270/Q2P27168
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM303061 (US9598447, Ref No. AA) Show SMILES CCOP(=O)(OCC)c1nc2ccccc2n([C@@H]2C[C@@H]3CC[C@H](C2)N3C23CC4CC2CC(C3)C4)c1=O |r,TLB:28:27:32:29.30,THB:25:24:17.18.23:20.21,28:29:32:33.27.26,30:31:29.28:26| Show InChI InChI=1S/C28H38N3O4P/c1-3-34-36(33,35-4-2)26-27(32)30(25-8-6-5-7-24(25)29-26)23-14-21-9-10-22(15-23)31(21)28-16-18-11-19(17-28)13-20(28)12-18/h5-8,18-23H,3-4,9-17H2,1-2H3/t18?,19?,20?,21-,22+,23+,28?	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	48.1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purdue Pharma L.P. US Patent					Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in ...				US Patent US9598447 (2017) BindingDB Entry DOI: 10.7270/Q2P27168
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM303061 (US9598447, Ref No. AA) Show SMILES CCOP(=O)(OCC)c1nc2ccccc2n([C@@H]2C[C@@H]3CC[C@H](C2)N3C23CC4CC2CC(C3)C4)c1=O |r,TLB:28:27:32:29.30,THB:25:24:17.18.23:20.21,28:29:32:33.27.26,30:31:29.28:26| Show InChI InChI=1S/C28H38N3O4P/c1-3-34-36(33,35-4-2)26-27(32)30(25-8-6-5-7-24(25)29-26)23-14-21-9-10-22(15-23)31(21)28-16-18-11-19(17-28)13-20(28)12-18/h5-8,18-23H,3-4,9-17H2,1-2H3/t18?,19?,20?,21-,22+,23+,28?	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	429	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purdue Pharma L.P. US Patent					Assay Description μ-Opioid Receptor Binding Assay Procedures: Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-rec...				US Patent US9598447 (2017) BindingDB Entry DOI: 10.7270/Q2P27168
					More data for this Ligand-Target Pair
Delta-type opioid receptor (Homo sapiens (Human))	BDBM303061 (US9598447, Ref No. AA) Show SMILES CCOP(=O)(OCC)c1nc2ccccc2n([C@@H]2C[C@@H]3CC[C@H](C2)N3C23CC4CC2CC(C3)C4)c1=O |r,TLB:28:27:32:29.30,THB:25:24:17.18.23:20.21,28:29:32:33.27.26,30:31:29.28:26| Show InChI InChI=1S/C28H38N3O4P/c1-3-34-36(33,35-4-2)26-27(32)30(25-8-6-5-7-24(25)29-26)23-14-21-9-10-22(15-23)31(21)28-16-18-11-19(17-28)13-20(28)12-18/h5-8,18-23H,3-4,9-17H2,1-2H3/t18?,19?,20?,21-,22+,23+,28?	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	2.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purdue Pharma L.P. US Patent					Assay Description δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...				US Patent US9598447 (2017) BindingDB Entry DOI: 10.7270/Q2P27168
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM303061 (US9598447, Ref No. AA) Show SMILES CCOP(=O)(OCC)c1nc2ccccc2n([C@@H]2C[C@@H]3CC[C@H](C2)N3C23CC4CC2CC(C3)C4)c1=O |r,TLB:28:27:32:29.30,THB:25:24:17.18.23:20.21,28:29:32:33.27.26,30:31:29.28:26| Show InChI InChI=1S/C28H38N3O4P/c1-3-34-36(33,35-4-2)26-27(32)30(25-8-6-5-7-24(25)29-26)23-14-21-9-10-22(15-23)31(21)28-16-18-11-19(17-28)13-20(28)12-18/h5-8,18-23H,3-4,9-17H2,1-2H3/t18?,19?,20?,21-,22+,23+,28?	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	184	n/a	n/a	n/a	n/a
Purdue Pharma L.P. US Patent					Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in ...				US Patent US9598447 (2017) BindingDB Entry DOI: 10.7270/Q2P27168
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM303061 (US9598447, Ref No. AA) Show SMILES CCOP(=O)(OCC)c1nc2ccccc2n([C@@H]2C[C@@H]3CC[C@H](C2)N3C23CC4CC2CC(C3)C4)c1=O |r,TLB:28:27:32:29.30,THB:25:24:17.18.23:20.21,28:29:32:33.27.26,30:31:29.28:26| Show InChI InChI=1S/C28H38N3O4P/c1-3-34-36(33,35-4-2)26-27(32)30(25-8-6-5-7-24(25)29-26)23-14-21-9-10-22(15-23)31(21)28-16-18-11-19(17-28)13-20(28)12-18/h5-8,18-23H,3-4,9-17H2,1-2H3/t18?,19?,20?,21-,22+,23+,28?	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.00E+4	n/a	n/a	n/a	n/a
Purdue Pharma L.P. US Patent					Assay Description μ-Opioid Receptor Binding Assay Procedures: Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-rec...				US Patent US9598447 (2017) BindingDB Entry DOI: 10.7270/Q2P27168
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM303061 (US9598447, Ref No. AA) Show SMILES CCOP(=O)(OCC)c1nc2ccccc2n([C@@H]2C[C@@H]3CC[C@H](C2)N3C23CC4CC2CC(C3)C4)c1=O |r,TLB:28:27:32:29.30,THB:25:24:17.18.23:20.21,28:29:32:33.27.26,30:31:29.28:26| Show InChI InChI=1S/C28H38N3O4P/c1-3-34-36(33,35-4-2)26-27(32)30(25-8-6-5-7-24(25)29-26)23-14-21-9-10-22(15-23)31(21)28-16-18-11-19(17-28)13-20(28)12-18/h5-8,18-23H,3-4,9-17H2,1-2H3/t18?,19?,20?,21-,22+,23+,28?	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.00E+4	n/a	n/a	n/a	n/a
Purdue Pharma L.P. US Patent					Assay Description κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...				US Patent US9598447 (2017) BindingDB Entry DOI: 10.7270/Q2P27168
					More data for this Ligand-Target Pair